tradingkey.logo

Anebulo rises as it weighs going-private deal after getting fresh options

ReutersSep 12, 2025 1:34 PM

** Shares of drug developer Anebulo Pharmaceuticals ANEB.O rise 16.9% to $2.35 in early morning trading

** Anebulo Pharmaceuticals says it is still considering a plan to go private after it first announced it in July 2025, but has also received interest from possible buyers and partners

** The company's board will review different options to maximize shareholder value, including the going-private deal with a reverse stock split, a potential sale of its assets, or a merger, the company says

** As of last close, ANEB was down 19.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI